|
US4678783B1
(en)
|
1983-11-04 |
1995-04-04 |
Asahi Chemical Ind |
Substituted isoquinolinesulfonyl compounds
|
|
EP1195372A1
(en)
|
1994-04-18 |
2002-04-10 |
Mitsubishi Pharma Corporation |
N-heterocyclic substituted benzamide derivatives with antihypertensive activity
|
|
JP3421217B2
(ja)
|
1995-11-20 |
2003-06-30 |
麒麟麦酒株式会社 |
Rho標的タンパク質Rhoキナーゼ
|
|
AU9646198A
(en)
|
1997-10-22 |
1999-05-10 |
Nippon Shinyaku Co. Ltd. |
Isoquinoline derivative and drug
|
|
WO1999061403A1
(en)
|
1998-05-25 |
1999-12-02 |
Santen Pharmaceutical Co., Ltd. |
Novel vinylbenzene derivatives
|
|
PE20020958A1
(es)
|
2001-03-23 |
2002-11-14 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
|
UY27224A1
(es)
|
2001-03-23 |
2002-10-31 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
|
US7109208B2
(en)
|
2001-04-11 |
2006-09-19 |
Senju Pharmaceutical Co., Ltd. |
Visual function disorder improving agents
|
|
WO2002100833A1
(en)
|
2001-06-12 |
2002-12-19 |
Sumitomo Pharmaceuticals Company, Limited |
Rho KINASE INHIBITORS
|
|
JP4505228B2
(ja)
|
2002-01-10 |
2010-07-21 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
Rho−キナーゼ阻害剤
|
|
MXPA04007196A
(es)
|
2002-01-23 |
2005-06-08 |
Bayer Pharmaceuticals Corp |
Inhibidores de rho-quinasa.
|
|
EP1541559A4
(en)
|
2002-07-22 |
2007-08-22 |
Asahi Kasei Pharma Corp |
5-SUBSTITUTED ISOQUINOLINE DERIVATIVE
|
|
CA2400996A1
(en)
|
2002-09-03 |
2004-03-03 |
Lisa Mckerracher |
1,4-substituted cyclohexane derivatives
|
|
US7160894B2
(en)
|
2003-06-06 |
2007-01-09 |
Asahi Kasei Pharma Corporation |
Tricyclic compound
|
|
WO2005003101A2
(en)
|
2003-07-02 |
2005-01-13 |
Biofocus Discovery Limited |
Pyrazine and pyridine derivatives as rho kinase inhibitors
|
|
WO2005039564A1
(en)
|
2003-10-02 |
2005-05-06 |
Vertex Pharmaceuticals Incorporated |
Phthalimide compounds useful as protein kinase inhibitors
|
|
ES2387780T3
(es)
|
2003-10-06 |
2012-10-01 |
Glaxosmithkline Llc |
Preparación de azabencimidazoles 1,6-disustituidos como inhibidores de quinasas
|
|
JP2007507547A
(ja)
|
2003-10-06 |
2007-03-29 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としての1,7−二置換アザベンゾイミダゾールの調製
|
|
WO2005034866A2
(en)
|
2003-10-06 |
2005-04-21 |
Glaxo Group Limited |
Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
|
|
EP1679308B1
(en)
|
2003-10-15 |
2013-07-24 |
Ube Industries, Ltd. |
Novel indazole derivative
|
|
JP2007008816A
(ja)
|
2003-10-15 |
2007-01-18 |
Ube Ind Ltd |
新規イソキノリン誘導体
|
|
JP2007015928A
(ja)
|
2003-10-15 |
2007-01-25 |
Ube Ind Ltd |
新規オレフィン誘導体
|
|
CA2556589A1
(en)
|
2004-02-24 |
2005-09-01 |
Bioaxone Therapeutique Inc. |
4-substituted piperidine derivatives
|
|
AR049333A1
(es)
|
2004-04-02 |
2006-07-19 |
Vertex Pharma |
Azaindoles inhibidores de proteinquinasas rock y otras proteinas quinasas. composiciones farmaceuticas.
|
|
DE102004017438A1
(de)
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
|
WO2006057270A1
(ja)
|
2004-11-26 |
2006-06-01 |
Asahi Kasei Pharma Corporation |
含窒素3環化合物
|
|
CA2621181C
(en)
|
2005-08-30 |
2011-04-19 |
Asahi Kasei Pharma Corporation |
5-isoquinolinesulfonamide compounds
|
|
ES2729424T3
(es)
|
2006-09-20 |
2019-11-04 |
Aerie Pharmaceuticals Inc |
Inhibidores de Rho cinasa
|
|
JP5421783B2
(ja)
|
2006-12-27 |
2014-02-19 |
サノフイ |
Rhoキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
|
|
MX2011009568A
(es)
|
2009-03-09 |
2011-12-06 |
Surface Logix Inc |
Inhibidores de la rho cinasa.
|
|
WO2011107608A1
(en)
|
2010-03-02 |
2011-09-09 |
Amakem Nv |
Heterocyclic amides as rock inhibitors
|
|
GB201107223D0
(en)
|
2011-04-29 |
2011-06-15 |
Amakem Nv |
Novel rock inhibitors
|
|
JP2014525425A
(ja)
|
2011-08-31 |
2014-09-29 |
アマケン エンヴェー |
新規のrockキナーゼ阻害剤
|
|
PL2903618T3
(pl)
|
2012-10-05 |
2022-09-19 |
Kadmon Corporation, Llc |
Inhibitory kinazy rho
|
|
IN2015DN04311A
(https=)
|
2012-10-31 |
2015-10-16 |
Amakem Nv |
|
|
CA2898440A1
(en)
|
2013-01-18 |
2014-07-24 |
Bristol-Myers Squibb Company |
Phthalazinones and isoquinolinones as rock inhibitors
|
|
CN105308175B
(zh)
*
|
2013-03-11 |
2018-09-21 |
日本化学研究株式会社 |
人角膜上皮片的制造法
|
|
AR096788A1
(es)
|
2013-07-02 |
2016-02-03 |
Bristol Myers Squibb Co |
Compuestos tricíclicos de carboxamida como inhibidores potentes de rock
|
|
WO2015002926A1
(en)
|
2013-07-02 |
2015-01-08 |
Bristol-Myers Squibb Company |
Tricyclic pyrido-carboxamide derivatives as rock inhibitors
|
|
CN104903312B
(zh)
|
2013-10-07 |
2019-01-29 |
卡德门企业有限公司 |
Rho激酶抑制剂
|
|
ES2774923T3
(es)
|
2014-04-28 |
2020-07-23 |
China Resources Pharmaceutical Holdings Company Ltd |
Derivados de isoquinolinsulfonilo como inhibidores de RHO quinasa
|
|
JP6633618B2
(ja)
|
2014-08-21 |
2020-01-22 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
強力なrock阻害剤としてのタイドバックのベンズアミド誘導体
|
|
AR103990A1
(es)
|
2015-01-09 |
2017-06-21 |
Bristol Myers Squibb Co |
Ureas cíclicas como inhibidoras de rock
|
|
JP7323290B2
(ja)
*
|
2015-11-16 |
2023-08-08 |
アクロン・バイオテクノロジー・リミテッド・ライアビリティ・カンパニー |
凍結保存組成物およびその使用方法
|
|
AR107354A1
(es)
|
2016-01-13 |
2018-04-18 |
Bristol Myers Squibb Co |
Salicilamidas espiroheptanos y compuestos relacionados como inhibidores de rock
|
|
ES2781309T3
(es)
|
2016-05-27 |
2020-09-01 |
Bristol Myers Squibb Co |
Triazolonas y tetrazolonas como inhibidores de ROCK
|
|
ES2821877T3
(es)
|
2016-07-07 |
2021-04-28 |
Bristol Myers Squibb Co |
Espirolactamas como inhibidores de ROCK
|
|
JP7155102B2
(ja)
|
2016-07-07 |
2022-10-18 |
ブリストル-マイヤーズ スクイブ カンパニー |
Rock阻害剤としてのスピロ縮合環尿素
|
|
EP3481816B1
(en)
|
2016-07-07 |
2020-06-24 |
Bristol-Myers Squibb Company |
Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors
|
|
WO2018102325A1
(en)
|
2016-11-30 |
2018-06-07 |
Bristol-Myers Squibb Company |
Tricyclic rho kinase inhibitors
|
|
EP4509138A3
(en)
|
2016-12-21 |
2025-04-23 |
BioAxone BioSciences, Inc. |
Rho kinase inhibitor ba-1049 (r) and active metabolites thereof
|
|
TWI800498B
(zh)
|
2016-12-21 |
2023-05-01 |
義大利商吉斯藥品公司 |
作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物
|
|
GEP20207202B
(en)
|
2017-01-30 |
2020-12-25 |
Chiesi Farm Spa |
Tyrosine amide derivatives as rho-kinase inhibitors
|
|
CN110869360B
(zh)
|
2017-07-12 |
2023-12-15 |
百时美施贵宝公司 |
作为rock抑制剂的苯乙酰胺类
|
|
EP3652167B1
(en)
|
2017-07-12 |
2021-06-02 |
Bristol-Myers Squibb Company |
Spiroheptanyl hydantoins as rock inhibitors
|
|
JP6973731B2
(ja)
*
|
2017-07-25 |
2021-12-01 |
国立大学法人京都大学 |
ヒト多能性幹細胞由来心筋細胞の凍結方法
|
|
WO2019089868A1
(en)
|
2017-11-03 |
2019-05-09 |
Bristol-Myers Squibb Company |
Diazaspiro rock inhibitors
|
|
CA3110114A1
(en)
*
|
2018-08-22 |
2020-02-27 |
The Governors Of The University Of Alberta |
Cryopreservation of cell monolayers
|
|
US20210207088A1
(en)
*
|
2018-08-31 |
2021-07-08 |
The Doshisha |
Composition and method for preserving or culturing ocular cells
|
|
WO2020166711A1
(ja)
*
|
2019-02-15 |
2020-08-20 |
イビデン株式会社 |
凍結保存液
|
|
JP2020162533A
(ja)
*
|
2019-03-29 |
2020-10-08 |
群栄化学工業株式会社 |
細胞凍結保存方法、細胞凍結保存用組成物、および細胞凍結保存用培地
|
|
JP2020202772A
(ja)
*
|
2019-06-17 |
2020-12-24 |
三菱製紙株式会社 |
凍結保存用治具
|
|
US11556317B2
(en)
|
2020-05-22 |
2023-01-17 |
Fujitsu Limited |
Instruction translation support method and information processing apparatus
|